(NASDAQ: NSPR) Inspiremd's forecast annual revenue growth rate of -5.35% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 3.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.66%.
Inspiremd's revenue in 2026 is $10,560,000.On average, 5 Wall Street analysts forecast NSPR's revenue for 2026 to be $541,003,753, with the lowest NSPR revenue forecast at $498,621,968, and the highest NSPR revenue forecast at $584,089,194.
In 2027, NSPR is forecast to generate $1,111,452,832 in revenue, with the lowest revenue forecast at $850,017,302 and the highest revenue forecast at $1,493,051,277.